Animal diagnostics maker IDEXX Laboratories on Thursday raised its annual profit forecast after it beat Wall Street estimates for quarterly profit, as it benefited from customer retention and ...

IDEXX Laboratories, Inc. is a member of the S&P 500 ® Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 ...

IDEXX Laboratories, Inc. is a member of the S&P 500 ® Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX)’s share price is up by 2.6% over the past month. Over the past five years, IDEXX has been up 50% in the last five years, which is less than the market return.

Shares of IDEXX Laboratories (IDXX) surged 10% to lead S&P 500 gainers Monday after the provider of veterinary healthcare products and services reported better-than-anticipated results on demand ...

Idexx Laboratories posted a Q3 EPS of $2.79, beating estimates, though revenue of $975.54 million fell short. Veterinary trends and guidance update key 2024 outlook.

To listen to the live conference call, please dial 1-800-289-0462 or 1-323-794-2442 and reference passcode 205740. About IDEXX Laboratories, Inc. IDEXX is a global leader in pet healthcare innovation.

In the wake of the COVID-19 pandemic, telemedicine quickly emerged as a viable, convenient alternative to traditional care. However, with this rapid growth came significant, unforeseen challenges.

IDEXX growth continues to expand at a high premium to US same-store clinical visit levels which decline 1.8% in Q2. In the US diagnostic utilization per clinical visit continues to expand ...